openPR Logo
Press release

Global Familial Adenomatous Polyposis Market Key Players 2018 – Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc, and Thetis Pharmaceuticals LLC Forecast to 2022

03-05-2018 10:29 AM CET | Health & Medicine

Press release from: WISEGUY RESEARCH CONSULTANTS PVT LTD

/ PR Agency: WISEGUY RESEARCH CONSULTANTS PVT LTD
Familial Adenomatous Polyposis

Familial Adenomatous Polyposis

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Familial Adenomatous Polyposis - Pipeline Review, H1 2018”

Familial Adenomatous Polyposis

Overview

Familial adenomatous polyposis (FAP) or classic FAP is a genetic condition that causes extra tissue (polyps) to form in large intestine and rectum. It is caused by germline mutations in the APC gene. Symptoms include blood or mucus in the stools, diarrhea or constipation, weight loss due to unknown reason and abdominal pain. Treatment includes surgery and medications (NSAIDs).

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3031092-familial-adenomatous-polyposis-pipeline-review-h1-2018

 

Major Key Players:

Cancer Prevention Pharmaceuticals Inc

Marina Biotech Inc

Thetis Pharmaceuticals LLC

Familial Adenomatous Polyposis Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Familial Adenomatous Polyposis    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Familial Adenomatous Polyposis   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Familial Adenomatous Polyposis (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Familial Adenomatous Polyposis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Unknown stages are 2, 1, 3 and 1 respectively.

Familial Adenomatous Polyposis pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Familial Adenomatous Polyposis - Competitive Analysis

Key players are making innovative developments in Familial Adenomatous Polyposis industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Familial Adenomatous Polyposis.

The pipeline guide reviews pipeline therapeutics for Familial Adenomatous Polyposis by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Familial Adenomatous Polyposis therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Familial Adenomatous Polyposis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Familial Adenomatous Polyposis.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3031092-familial-adenomatous-polyposis-pipeline-review-h1-2018

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Familial Adenomatous Polyposis Market Key Players 2018 – Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc, and Thetis Pharmaceuticals LLC Forecast to 2022 here

News-ID: 964159 • Views:

More Releases from WISEGUY RESEARCH CONSULTANTS PVT LTD

Assistive and Rehabilitation Robotic Market 2020 : Global Industry Trends And Forecasts Analysis To 2025
Assistive and Rehabilitation Robotic Market 2020 : Global Industry Trends And Fo …
WiseGuyReports.Com Publish a New Market Research Report On –“ Assistive and Rehabilitation Robotic Market 2020 : Global Industry Trends And Forecasts Analysis To 2025”. Assistive and Rehabilitation Robotic Market 2020 Description: - The report predicts the forecast of the Assistive and Rehabilitation Robotic industry after a series of extensive research, and it addresses the recent status of the industry, as well. The latest report discusses every possible outcome of the industry in the
Automotive Throttle Body Assembly 2020 Market - Global Industry Size,Growth,Trends,Analysis,Opportunities, And Forecasts To 2025
Automotive Throttle Body Assembly 2020 Market - Global Industry Size,Growth,Tren …
WiseGuyReports.Com Publish a New Market Research Report On –“ Automotive Throttle Body Assembly 2020 Market - Global Industry Size,Growth,Trends,Analysis,Opportunities, And Forecasts To 2025”. Automotive Throttle Body Assembly Market 2020 Description: - The report predicts the forecast of the Automotive Throttle Body Assembly industry after a series of extensive research, and it addresses the recent status of the industry, as well. The latest report discusses every possible outcome of the industry in the future.
Automotive Diesel Filters Market 2020 : Global Industry Trends And Forecasts Analysis To 2025
Automotive Diesel Filters Market 2020 : Global Industry Trends And Forecasts Ana …
WiseGuyReports.Com Publish a New Market Research Report On –“ Automotive Diesel Filters Market 2020 : Global Industry Trends And Forecasts Analysis To 2025”. Automotive Diesel Filters Market 2020 Description: - The report predicts the forecast of the Automotive Diesel Filters industry after a series of extensive research, and it addresses the recent status of the industry, as well. The latest report discusses every possible outcome of the industry in the future. The overview
Propanol Market 2020 Major Manufacturers Analysis And Industrial Applications Forecasts To 2025
Propanol Market 2020 Major Manufacturers Analysis And Industrial Applications Fo …
WiseGuyReports.Com Publish a New Market Research Report On –“ Propanol Market 2020 Major Manufacturers Analysis And Industrial Applications Forecasts To 2025”. Propanol Market 2020 Description: - The report predicts the forecast of the Propanol industry after a series of extensive research, and it addresses the recent status of the industry, as well. The latest report discusses every possible outcome of the industry in the future. The overview of the report shares some useful

All 5 Releases


More Releases for Familial

Homozygous Familial Hypercholesterolemia (HoFH) Market Massive Growth opportunit …
Introduction Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic lipid disorder characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels from birth, often exceeding 500 mg/dL. Caused by mutations in both alleles of the LDLR, APOB, or PCSK9 genes, HoFH leads to early-onset atherosclerosis, cardiovascular disease, and premature mortality if untreated. Historically, management relied on lipid-lowering agents, LDL apheresis, and lifestyle modifications. However, the last decade has witnessed a paradigm shift with
Familial Adenomatous Polyposis (FAP) Therapeutics- Pipeline Analysis 2018
Familial adenomatous polyposis (FAP) is a genetic disorder, characterized by the development of adenomatous colon polyps in the intestinal tract, resulting in colon cancer. The disease is diagnosed when more than 100 adenomatous colon polyps are developed in a person. Download the sample report at: https://www.pharmaproff.com/request-sample/1025 A person with FAP is at a high risk of developing cancer of small intestines or stomach. This disease is categorized into three types including attenuated
Heterozygous Familial Hypercholesterolemia (heFH) Therapeutics - Pipeline Analys …
Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder that affects the body’s ability to control cholesterol. It is characterized by very high LDL (low density lipoprotein) cholesterol (above 190 for adults or above 160 for children) and family history of high cholesterol, heart disease or stroke. Download the sample report @ https://www.pharmaproff.com/request-sample/1135 A very high level of LDL from birth leads to a twenty-fold increase in the risk of premature
Familial Amyloid Cardiomyopathy Treatment Market Opportunity Analysis, 2018–20 …
Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy is also known as hereditary cardiac transthyretin amyloidosis or hereditary amyloid cardiomyopathy. The protein transthyretin amyloid fibrils infiltrate the myocardium that leads to diastolic dysfunction from restrictive cardiomyopathy, which eventually result to heart failure. There are several mutation in TTR which are associated
Familial Adenomatous Polyposis Pipeline Therapeutics Development Market Review 2 …
RnRMarketResearch.com adds “Familial Adenomatous Polyposis - Pipeline Review, H1 2017” to its store providing an overview of the Familial Adenomatous Polyposis therapeutic pipeline with comprehensive information on the therapeutic development for Familial Adenomatous Polyposis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews
Familial Adenomatous Polyposis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Familial Adenomatous Polyposis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous Polyposis - Pipeline Review, H1 2017, provides an overview of the Familial Adenomatous Polyposis (Genetic Disorders) pipeline landscape. Familial adenomatous polyposis (FAP) is also known as familial polyposis coli, adenomatous polyposis coli, or